Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

NCT04452877

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Novartis Investigative Site Harbin, Heilongjiang, China
  • Novartis Investigative Site Changsha, Hunan, China
  • Novartis Investigative Site Chengdu, Sichuan, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
View Trial Details
Completed

A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)

NCT02998528

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0121 Glendale, Arizona, United States
  • Local Institution - 0081 Los Angeles, California, United States
  • Local Institution - 0025 Denver, Colorado, United States
  • Local Institution - 0007 Plainville, Connecticut, United States
View all 138 locations
View Trial Details
Completed

A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

NCT06029127

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Daping Hospital, Third Military Medical University Chongqing, Chongqing Municipality, China
  • Gansu Provincial Hospital Lanzhou, Gansu, China
  • The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Completed

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

NCT04490564

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • University General Hospital of Alexandroupoli Alexandroupoli, Alexandroupolis, Greece
  • Sotiria Thoracic Diseases Hospital of Athens Athens, Attica, Greece
  • Aretaieio University Hospital of Athens Athens, Attica, Greece
  • University General Hospital of Athens Attikon Athens, Attica, Greece
View Trial Details

Related conditions